EU blows top: Brussels 'to END vaccine partnership with AstraZeneca and Johnson & Johnson'

Following issues with both companies, the EU Commission will not renew its deal with either company and will focus on the Pfizer and Moderna vaccines. 

According to a source, the EU Commission has been supported by several EU states with its decision. 

Both AstraZeneca and J&J have experienced supply issues forcing the EU Commission to focus on vaccines using the RNA messenger. 

This is a breaking news story, more to follow…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button